---
figid: PMC6874786__Cell-J-22-193-g01
figlink: pmc/articles/PMC6874786/figure/F1/
number: F1
caption: Overview of the PI3K/AKT/mTOR pathway in AML. The PI3K/AKT/mTOR pathway and
  other pathways related to AML, Inducing autophagy by inhibiting the mTOR pathway.
  Diagram shows that ATO promotes apoptotic mechanisms. Left, PI3K/Akt/NF-κB pathway
  permanently activated in the absence of ATO. Right, ATO by inducing JNK activation,
  can inhibit the PI3K/Akt/NF-κB signalling pathway. THAL has anti-angiogenesis effects
  on tumour growth and progression. THAL inhibits IL6. ATO/THAL by inhibition of mTORC1
  induces dephosphorylation of ULK1 and subsequent ULK1-mediated phosphorylation of
  ATG13, FIP200 and ULK1 itself, inducing autophagosome synthesis. Release of BCL-2
  suppresses BECLIN1 that induces autophagy through disruption of the BCL-2/BCL- XL-BECLIN1
  interaction. In case of existence of sufficient nutrients, BECLIN1 binds to BCL-2
  or BCL-XL, and loses its ability to initiate autophagy. AML; Acute myeloid leukemia,
  ATO; Arsenic trioxide, and THAL; Thalidomide.
pmcid: PMC6874786
papertitle: Arsenic Trioxide and Thalidomide Combination Induces Autophagy Along with
  Apoptosis in Acute Myeloid Cell Lines.
reftext: Mahnaz Mohammadi Kian, et al. Cell J. 2020 Summer;22(2):193-202.
pmc_ranked_result_index: '3043'
pathway_score: 0.9588603
filename: Cell-J-22-193-g01.jpg
figtitle: PI3K/AKT/mTOR pathway in AML
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6874786__Cell-J-22-193-g01.html
  '@type': Dataset
  description: Overview of the PI3K/AKT/mTOR pathway in AML. The PI3K/AKT/mTOR pathway
    and other pathways related to AML, Inducing autophagy by inhibiting the mTOR pathway.
    Diagram shows that ATO promotes apoptotic mechanisms. Left, PI3K/Akt/NF-κB pathway
    permanently activated in the absence of ATO. Right, ATO by inducing JNK activation,
    can inhibit the PI3K/Akt/NF-κB signalling pathway. THAL has anti-angiogenesis
    effects on tumour growth and progression. THAL inhibits IL6. ATO/THAL by inhibition
    of mTORC1 induces dephosphorylation of ULK1 and subsequent ULK1-mediated phosphorylation
    of ATG13, FIP200 and ULK1 itself, inducing autophagosome synthesis. Release of
    BCL-2 suppresses BECLIN1 that induces autophagy through disruption of the BCL-2/BCL-
    XL-BECLIN1 interaction. In case of existence of sufficient nutrients, BECLIN1
    binds to BCL-2 or BCL-XL, and loses its ability to initiate autophagy. AML; Acute
    myeloid leukemia, ATO; Arsenic trioxide, and THAL; Thalidomide.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HRAS
  - KRAS
  - NRAS
  - MAPK8
  - MAPK9
  - MAPK10
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - PTEN
  - ARAF
  - BRAF
  - RAF1
  - AKT2
  - AKT3
  - AKT1
  - MAP2K1
  - MAP2K2
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - RPTOR
  - MTOR
  - MAPK3
  - MAPK1
  - IL6
  - STAT3
  - MYC
  - ATG5
  - ATG7
  - BAX
  - BCL2
  - ATG12
  - ATO
genes:
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: mTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: mTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: IL6
  symbol: IL6
  source: hgnc_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: c-MYC
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: ATG5
  symbol: ATG5
  source: hgnc_symbol
  hgnc_symbol: ATG5
  entrez: '9474'
- word: ATG7
  symbol: ATG7
  source: hgnc_symbol
  hgnc_symbol: ATG7
  entrez: '10533'
- word: BAX
  symbol: BAX
  source: hgnc_symbol
  hgnc_symbol: BAX
  entrez: '581'
- word: Bcl-2
  symbol: Bcl-2
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: ATG12
  symbol: ATG12
  source: hgnc_symbol
  hgnc_symbol: ATG12
  entrez: '9140'
chemicals:
- word: ATO
  source: MESH
  identifier: C553022
diseases: []
figid_alias: PMC6874786__F1
redirect_from: /figures/PMC6874786__F1
figtype: Figure
---
